Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 5, 2021
Patent Application Number
16214783
Date Filed
December 10, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to methods of treating disorders in which DOT1L-mediated protein methylation plays a part, such as cancer, by administering DOT1L inhibitor compounds and pharmaceutical compositions to subjects in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
